(Q41755895)
Statements
1 reference
Intermittent oral 1alpha-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients. 1alphaD2 Study Group (English)
1 reference
Frazao JM
1 reference
Chesney RW
1 reference
Coburn JW
1 reference
1 January 1998
1 reference
1 reference
13 Suppl 3
1 reference
68-72
1 reference
Identifiers
1 reference
1 reference